The novel treatment of the medication represents a exciting advance in the handling of the condition. Distinct from existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide234798.bloggactif.com/43511814/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment